title: Myeloid-positive T cell acute leukemia after treatment of infantile neuroblastoma.
authors.affiliation: Department of Pediatrics, Yamaguchi University School of Medicine, Yamaguchi, Japan. ayukawa@po.ci.yamaguchi-u.ac.jp
authors.forename: H
authors.initials: H
authors.lastname: Ayukawa
authors.forename: Y
authors.initials: Y
authors.lastname: Umemoto
authors.forename: K
authors.initials: K
authors.lastname: Kawasaki
authors.forename: M
authors.initials: M
authors.lastname: Koga
authors.forename: S
authors.initials: S
authors.lastname: Furukawa
authors.forename: Y
authors.initials: Y
authors.lastname: Ikuno
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D007223:Infant; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000139:chemically induced*; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D009447:Neuroblastoma / Q000188:drug therapy*
chemical_list: D004317:Doxorubicin; D003520:Cyclophosphamide; C027260:pirarubicin